Our Approach

Bringing personalized Big Data to your fingertips.
Disease-Specific

Channelopathies,
Neuropathies &
Muscle Disorders

Pharmacogenomics

Common Variants &
Risk SNPs

Personalized Drug Screens

High-Throughput,
Lead Identification &
Combination Testing

Data Visualization

Cloud-Based,
Intuitive &
User-Friendly

Our Technology

Integrating pharmacogenomics and individualized ex vivo drug screens
using novel algorithms to bring Big Data to a user-friendly interface.
The Personalized Medicine Approach



Using data from pharmacogenomics and patient-specific drug screens, our algorithms help analyze and visualize Big Data 'on the fly'.

Our cloud-based interface facilitates collaboration, and further identifies the best-in-class drug for each patient.

  • Disease-Specific

    Focused

  • Patient-Specific

    Precise

  • Big Data Driven

    Scale

  • Friendly Analytics

    Easy

University of Toronto Faculty of Medicine Health Innovation Hub

OUR PUBLICATIONS

PubMed

Testimonials

PACKAGES

Choose from 3 Different Software Packages

OPTI-Rx™

Basic Package

USD$199

/MONTH
  • Disease-Specific
  • Patient-Specific
  • Cloud-Based Analytics
  • PC / Smart Phone / Tablet
  • Single Token
PURCHASE

OPTI-RX+™

Premium Package

USD$TBD

/MONTH
  • Disease-Specific
  • Patient-Specific
  • Cloud-Based Analytics
  • PC / Smart Phone / Tablet
  • Multiple Tokens
COMING SOON!

DISCOVERY

Ultimate Package

USD$TBD

/MONTH
  • Disease-Specific
  • Patient-Specific
  • Cloud-Based Analytics
  • PC / Smart Phone / Tablet
  • Custom Software & Dashboard
  • Unlimited Tokens
COMING SOON!

Our Team

Meet the Co-Founders
Saumel Ahmadi
Saumel Ahmadi
CEO
Saumel received his MD from Saurashtra University in India. He is currently completing his PhD (Physiology) at the University of Toronto while working at The Hospital for Sick Children.
Zoltán Bozóky
Zoltán Bozóky
CTO
Zoltan received his MSc (Chemistry) and PhD (Structural Biology) from the Eotvos Lorand University in Hungary. He also holds a Degree in Computer Science from the Graf Iskola kft. in Hungary. He recently completed his postdoctoral training at the Hospital for Sick Children.
Steven Molinski
Steven Molinski
CSO
Steven received his HonBSc (Toxicology) from the University of Toronto, MSc (Pharmacology) from Queen’s University, and PhD (Biochemistry) from the University of Toronto while working at The Hospital for Sick Children.

OUR ADVISORS

Dr. Danny C. Li
Dr. Danny C. Li
Scientific Advisor
Program Coordinator,
Traditional Chinese Medicine

School of Health Science,
Humber College
Jonathan Rezek
Jonathan Rezek
Technical Advisor
Executive,
Business Development

Innovation Centre,
IBM Canada
Dr. Nana Lee
Dr. Nana Lee
Strategic Advisor
Director and Lecturer,
Biochemistry and Immunology

Faculty of Medicine,
University of Toronto

OUR OFFICES

40 Gerrard Street East
Toronto, ON, Canada
M5B 2M2
Borups Alle 126C, 2000
Copenhagen, Denmark

Contact Us

Request an Information Package

“Personalized Big Data at your Fingertips”

Taking your Big Data to the next level in order to assist:
(1) patients, (2) healthcare system & (3) insurance providers

XVIVOS Biosciences - Recipient of 2016 HealthEDGE Fellowship